The largest database of trusted experimental protocols
> Chemicals & Drugs > Antibiotic > Minocycline

Minocycline

Minocycline is a tetracycline antibiotic used to treat a variety of bacterial infections.
It is effective against both gram-positive and gram-negative bacteria, and has been used to treat acne, rosacea, and other skin conditions.
Minocycline works by interfering with bacterial protein synthesis, preventing the bacteria from replicating.
It is available in oral and topical formulations, and is generally well-tolerated, though it can cause side effects such as discoloration of the skin and teeth.
Researchers continue to explore new applications and delivery methods for minocycline to optimize its efectiveness and safety.

Most cited protocols related to «Minocycline»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2008
Adenovirus Infections Agglutination Antibiotics Antigens, Viral Azithromycin Blood Culture Child Children's Health Chlamydophila pneumoniae Clindamycin Enzyme Immunoassay Erythromycin Fever Immunoglobulin M Macrolides Males Meridians Methylprednisolone Minocycline Mycoplasma Mycoplasma pneumoniae Nasopharynx Orthomyxoviridae pathogenesis Patients Pneumonia Pulse Rate Radiography, Thoracic Respiratory Rate Respiratory System Respiratory Tract Infections Serum Virus Woman X-Rays, Diagnostic
Mechanical sensitivity of the whisker pad, the infraorbital nerve receptive field, was measured with a series of 8 von Frey fiber filament (0.008 g (1.65); 0.02 g (2.36); 0.07 g (2.83); 0.16 g (3.22); 0.4 g (3.61); 1.0 g (4.08); 2.0 g (4.31); 6.0 g (4.74); Stoelting, Wood Dale, IL) by modified up-down method. Mice were handled several times before experiments. One experimenter held the mouse with two hands in insulating cotton gloves until the animal was calm. Animal moved freely in the holder’s hands with its head exposed as shown in Figure 1B. During testing, one experimenter slightly restrains the mouse in their hands so that another experimenter could accurately apply the von Frey filament onto the center of the mouse whisker pad, both ipsilateral and contralateral to the surgery site. For consistency of results, each filament was applied five times at intervals of a few seconds. If head withdrawal was observed at least three times after probing with a filament, the mouse was considered responsive to that filament according to the up-down method [37 (link),38 (link)]. For this approach, whenever a positive response to the mechanical stimulus occurred, the next weaker von Frey filament was applied. If no positive response is evoked, the next stronger filament was applied. Testing proceeded in this manner until four fibers applied after the first one successfully caused positive responses. This allowed estimation of the 50% mechanical withdrawal threshold (in gram) using a curve-fitting algorithm. The mechanical thresholds on the whisker pads of both sides were measured on day 3 and 7 in the first week and then once a week for 10 weeks after surgery. To test effects of drugs on the behavioral changes, mechanical allodynia was confirmed in the mice after induction of TIC nerve trauma in the late weeks of experimental period. Minocycline, A438079 and SB203580 were each injected into mice intraperitoneally. The behavioral changes were tested at 0.5, 1, 3 and 6 h after drug administration except minocycline which had a 1 h testing duration. To conserve animals, mice were tested with all drugs but with only one drug per week allowing recovery time before another drug was tested.
Full text: Click here
Publication 2012
A-438079 Animals ARID1A protein, human Cardiac Arrest Cytoskeletal Filaments Fibrosis Gossypium Head Hypersensitivity Mechanical Allodynia Minocycline Mus Neoplasm Metastasis Nervousness Operative Surgical Procedures Pharmaceutical Preparations SB 203580 Substance Abuse Detection Vibrissae Wounds and Injuries
Surgery consisted of an open tibial fracture of the left hind paw with intramedullary fixation in aseptic conditions under general anesthesia with isoflurane and buprenorphine as previously described.13 (link) Other than surgery, C57BL/6J mice received anesthesia/analgesia alone, or underwent surgery with concurrent administration of minocycline, enrofloxacin, or IL-1 receptor antagonist (IL-1Ra), or were not subjected to any intervention (naive). Positive controls were injected intraperitoneally (i.p.) with lipopolysaccharide (LPS) 1mg/kg. In other experiments, IL-1R−/− and IL-1R+/+ mice were naive or subjected to surgery under anesthesia. An additional group of WT mice also received preemptive administration of IL-1Ra before surgery.
Publication 2010
Anesthesia Anesthesia and Analgesia Asepsis Buprenorphine Enrofloxacin General Anesthesia Isoflurane Lipopolysaccharides Mice, Inbred C57BL Minocycline Mus Operative Surgical Procedures Receptors, Interleukin-1 Tibial Fractures
This randomized clinical trial involved two research centers—The Karolinska Institute in Sweden (KI) and Helperby Therapeutics Ltd. in the United Kingdom (HP). Each study was approved by the respective institutional boards and the respective national competent authorities and was registered with the European Union Clinical Trials Register (for details, see Text S1 in the supplemental material). Each center involved healthy volunteers, randomized into two test groups and one control group. At KI, 30 volunteers were randomly assigned to either the ciprofloxacin (Cipro), the clindamycin (Clinda), or the placebo (Plac KI) group. At HP, 44 volunteers were randomly assigned to the amoxicillin (Amox, n = 15), the minocycline (Minoc, n = 15), or the placebo (Plac HP, n = 14) group. Saliva and fecal samples were collected on 6 occasions: immediately before administration of the antibiotic (baseline), immediately after the treatment course was completed (week 1), and 1 month, 2 months, 4 months, and 12 months postdosing. Sample DNA was extracted, 16S rRNA gene amplicons were sequenced, and data were processed as described previously (36 (link)– (link)38 (link)) (see Text S1).
Publication 2015
5'-palmitoyl cytarabine Amoxicillin Antibiotics Ciprofloxacin Clindamycin Feces Healthy Volunteers Minocycline Placebos Ribosomal RNA Genes Saliva Voluntary Workers
All reagents were high grade and were purchased from Sigma with the following exceptions. RPMI, DMEM, Calcein and ethidium homodimer and other culture reagents were purchased from Invitrogen Inc (Grand Island, NY, USA) and the UCSF cell culture facility (UCSF, San Francisco, CA). Fetal bovine Serum Defined (FBS) was purchased from Hyclone Laboratories (Logan, UT, USA). PD98059, a MEK inhibitor; SP600 125, a JNK inhibitor; wortmanin an inhibitor of PI3 kinase and pyrrolidinecarbodithoic acid (PDTC), a NF-κB inhibitor); AG490, a JAK2-STAT inhibitor were purchased from Calbiochem (San Diego, CA). LPS (Escherichia coli, O26:B6), aminoguandine, apocynin, allopurinol, minocycline, N(omega)-hydroxy-L-arginine (NOHA), indomethacin and amino-3-morpholinyl-1,2,3-oxadiazolium chloride (SIN-1) were purchased from Sigma (St Louis, MO). Drugs were dissolved in DMSO or ethanol and stored at -20°C and either used (final concentration of vehicle 0.1% (v/v or dried down and resuspended in PBS/0.1% bovine serum albumin (BSA). Mitogen activated kinase (MAPK) Anti-phospho-ERK monoclonal antibody (mAb), anti-ERK polyclonal antibody (#4370), anti-phospho-p38 MAPK mAb (# 4631), anti-phospho-JNK/SAPK mAb (#4668) were from Cell Signaling Technology (Danvers, MA); anti-NF-κBp65 (# SC-8008), anti-IκBα (# SC-1643) and respective horseradish peroxidase-coupled secondary antibodies were purchased from Santa Cruz (Santa Cruz, CA) and. Antibodies against iNOS ( # 61043), iNOS positive control lysates (#611473) were from BD Biosciences (BD Biosciences, Lexington, KY).
Full text: Click here
Publication 2011
1-Phosphatidylinositol 3-Kinase acetovanillone Acids AG-490 Allopurinol alpha, NF-KappaB Inhibitor Antibodies Antibodies, Anti-Idiotypic Arginine Cell Culture Techniques Chlorides Escherichia coli Ethanol ethidium homodimer fluorexon Horseradish Peroxidase I-kappa B Proteins Indomethacin JAK2 protein, human Minocycline Mitogens Monoclonal Antibodies NOS2A protein, human PD 98059 Pharmaceutical Preparations Phosphotransferases prolinedithiocarbamate Serum Albumin, Bovine Sulfoxide, Dimethyl

Most recents protocols related to «Minocycline»

All patients routinely received perianal screening for CRE within 48 hours of each hospital admission. In addition, some patients received perianal bacterial culture tests when they were suspected of infection by a competent physician during hospitalization. Perianal skin and throat swab samples were collected and submitted for examination by specially trained medical staff. Bacterial culture, identification and drug sensitivity test were conducted by special technicians in the microbiology laboratory, and the target bacteria were CRE. All CRE strains were isolated from perianal skin swabs and blood samples. Blood culture was performed using an automatic blood culture system (BD, USA). The isolation and identification of bacteria were carried out strictly following the relevant provisions of the National Clinical Laboratory Procedures. VITEK 2 compact (bioMérieux, France) was used to identify the isolates and MALDI-TOF MS (bioMérieux, France) was used for further confirmation. Antibiotic susceptibility testing was performed in the microbiology laboratory of the hospital using an automated system (VITEK 2 Compact) with the broth microdilution and disk diffusion methods. The following antibiotics were tested: penicillins (ticarcillin, piperacillin), β-lactamase inhibitor combinations (amoxicillin/clavulanic acid, piperacillin/tazobactam, cefoperazone/sulbactam), cephalosporins (cefazolin, cefuroxime, ceftazidime, cefepime, cefotaxime, cefotetan, cefpodoxime, ceftizoxime), quinolones (levofloxacin, moxifloxacin, ciprofloxacin, norfloxacin), carbapenems (imipenem, meropenem, doripenem), aminoglycosides (amikacin, tobramycin), tetracyclines (tetracycline, minocycline), aztreonam, trimethoprim/sulfamethoxazole and tigecycline. The minimum inhibitory concentration (MIC) was measured according to the guidelines of the 31st Edition of the Clinical and Laboratory Standards Institute (CLSI) M100-Performance Standards for Antimicrobial Susceptibility Testing.14 The detection of carbapenemases in CRE according to the modified carbapenem inactivation assay (mCIM and eCIM) provided by the CLSI 31th Edition.
Publication 2023
Amikacin Aminoglycosides Amox clav Antibiotics Aztreonam Bacteria beta-Lactamase Inhibitors Biological Assay Blood Blood Culture carbapenemase Carbapenems Cefazolin Cefepime Cefoperazone Cefotaxime Cefotetan cefpodoxime Ceftazidime Ceftizoxime Cefuroxime Cephalosporins Ciprofloxacin Clinical Laboratory Services Clinical Laboratory Techniques Diffusion Doripenem Hemic System Hospitalization Hypersensitivity Imipenem Infection isolation Levofloxacin Medical Staff Meropenem Microbicides Minimum Inhibitory Concentration Minocycline Moxifloxacin Norfloxacin Patients Penicillins Pharynx Physicians Piperacillin Piperacillin-Tazobactam Combination Product Quinolones Skin Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Strains Substance Abuse Detection Sulbactam Susceptibility, Disease Tetracycline Tetracyclines Ticarcillin Tigecycline Tobramycin Trimethoprim-Sulfamethoxazole Combination
The antimicrobial resistance profiles were provided by Phoenix BD automated system (Becton Dickinson Franklin Lakes, NJ, EUA); according to manufacturing protocols, each panel was standardized for Gram-positive and Gram-negative AST profiles comprehending the list below:
Aminoglycoside: Amikacin (AMK), Gentamicin (GEN), Synergism Gentamicin (SGEN), Synergism Streptomycin (SSTP), Tobramycin (TOB); Cephalosporins: Cefepime (FEP), Cefoxitin (FOX), Ceftaroline (CPT), Ceftazidime (CAZ), Ceftazidime + Avibactam (CZA), Ceftriaxone (CRO), Cefuroxime (CXM), Cefazolin (CZ); Quinolones: Ciprofloxacin (CIP), Norfloxacin (NX), Levofloxacin (LVX); Penicillin: Amoxicillin/Clavulanic acid (AMC), Ampicillin (AMP), Ampicillin/Sulbactam (SAM), Oxacillin (OXA), Penicillin (PEN), Piperacillin/Tazobactam (TZP); Carbapenems: Ertapenem (ETP), Imipenem (IPM), Meropenem (MEM); Glycopeptides: Teicoplanin (TEC), Vancomycin (VAN): Macrolide: Erythromycin (ERY), Rifampicin (RIP): Lincosamides: Clindamycin (CLI); Oxazolidinone: Linezolid (LZD); Tetracycline: Tetracycline (TET), Minocycline (MIN); Sulfonamides: Sulfamethoxazole/Trimethoprim (STX); Nitroimidazoles: Nitrofurantoin (NIT); Amphenicol: Chloramphenicol (C); Phosphonate: Fosfomycin (FOS); Glycylcyclines: Tigecycline (TGC); Polypeptide: Colistin (CL); Lipopeptides: Daptomycin (DAP).
The resistance profile was classified as resistant (R), and susceptible (S). Any isolate with resistance to three or more classes of antimicrobial agents was classified as multidrug-resistant (MDR) according to the definition proposed by Magiorakos et al. (2012) (link). Some of the clinical isolates were retrieved at the moment of hospitalization for epidemiological active surveillance and infection control. A total of 256 isolates were included in the study and 196 had the antimicrobial susceptibility test performed (Table 1).
Data for new COVID-19 cases for each month were obtained from the Brazilian Ministry of Health (MS) and the State Health Department of Rio de Janeiro, compiled by Cota (2020) .
The prevalence of bacteria species in pediatric, neonatal-ICU, and gynecology/obstetrics wards during the pandemic period was evaluated. In order to compare these three wards with other hospital wards, a total of 2,551 bacteria isolates were recovered from the HICC-HUAP.
Full text: Click here
Publication 2023
Amikacin Aminoglycosides Amox clav Amphenicol Ampicillin ampicillin-sulbactam avibactam - ceftazidime Bacteria Carbapenems Cefazolin Cefepime Cefoxitin ceftaroline Ceftazidime Ceftriaxone Cefuroxime Cephalosporins Chloramphenicol Ciprofloxacin Clindamycin Colistin COVID 19 Daptomycin Ertapenem Erythromycin Fosfomycin Gentamicin Glycopeptides glycylcycline Hospitalization Imipenem Infant, Newborn Infection Control Levofloxacin Lincosamides Linezolid Lipopeptides Macrolides Meropenem Microbicides Minocycline Nitrofurantoin Nitroimidazoles Norfloxacin Oxacillin Oxazolidinones Pandemics Penicillins Phosphonates Piperacillin-Tazobactam Combination Product Polypeptides Quinolones Rifampin Streptomycin Sulfonamides Susceptibility, Disease Teicoplanin Tetracycline Tigecycline Tobramycin Trimethoprim-Sulfamethoxazole Combination Vancomycin
We conducted a microbiological and genomic study using the preserved isolates collected from GCGS and SDSE isolates from the bacteremia cases during 2005–2021 in 3 hospitals: KUHP, KKH, and JRCOH. The bacterial isolates from patients’ blood samples were identified as GCGS when isolates showed large colony size (>0.5 mm), β-hemolysis on 5% sheep blood agar plate after overnight culture, and Lancefield grouping C or G. In some hospitals, GCGS isolates were then identified as SDSE by using phenotypic methods such as API 20 Strep (bioMérieux), BBL Crystal (Becton Dickinson Microbiology Systems), Microscan Walkaway System (Beckman Coulter, Inc.), or MALDI-TOF mass spectrometry. The study comprised 146 SDSE isolates collected during 2005–2021 (Appendix 1).
Lancefield grouping was performed using the Prolex Streptococcal Grouping Latex Kit (Pro Lab Diagnostics Inc.). Antimicrobial susceptibility testing was conducted by using the Microscan Walkaway System according to the manufacturers’ instructions or by broth microdilution by using customized dry plates (Eiken Chemical Co., Ltd). Susceptibility results were interpreted following Clinical Laboratory Standards Institute recommendations (16 ). Multidrug-resistant (MDR) was defined as nonsusceptibility to >2 antimicrobial agents; for this study, we refer to MDR as nonsusceptibility to erythromycin, minocycline, and clindamycin.
Full text: Click here
Publication 2023
Agar Bacteremia Bacteria Blood Clindamycin Clinical Laboratory Services Diagnosis Domestic Sheep Erythromycin Genome Hemolysis Latex Mass Spectrometry Microbicides Minocycline Patients Phenotype Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Streptococcal Infections Susceptibility, Disease
Antimicrobial susceptibility was tested using two different test methods. The susceptibility to cefazolin, amikacin, cefepime, ciprofloxacin, aztreonam, ceftriaxone, cefuroxime, ertapenem, piperacillin/tazobactam, ampicillin/sulbactam, amoxicillin/clavulanic acid, cefoperazone/sulbactam, gentamicin, cefoxitin, levofloxacin, minocycline, polymyxin, tetracycline, tigecycline, tobramycin, cotrimoxazole, ceftazidime, imipenem, and meropenem was tested with a BD Phoenix M50 fully automated microbial drug sensitivity analyzer (BD, Phoenix, AZ, USA) and MIC values were determined according to the manufacturer’s instruction. The Kirby–Bauer (KB) disc diffusion test determined the sensitivity of cefotaxime and ceftazidime/avibactam. A single colony was resuspended in a normal saline solution, and the turbidity was 0.46~0.54. The bacterial solution was uniformly spread on a Mueller–Hinton agar medium (Autobio, Zhengzhou, China) and a drug-sensitive paper sheet (Thermo Fisher, Waltham, MA, USA) was pasted on the agar plate inoculated with the bacteria to be tested and incubated at 35 °C for 24 h. Results were observed and determined by the size of the antibacterial zone. The drug sensitivity results of the two methods were analyzed according to the 2021 CLSI M100 Executive Standard for Antimicrobial Drug Sensitivity Testing [20 ,21 ].
Full text: Click here
Publication 2023
Agar Amikacin Amox clav ampicillin-sulbactam Anti-Bacterial Agents avibactam - ceftazidime Aztreonam Bacteria Cefazolin Cefepime Cefoperazone Cefotaxime Cefoxitin Ceftazidime Ceftriaxone Cefuroxime Ciprofloxacin Ertapenem Gentamicin Hypersensitivity Imipenem Kirby-Bauer Disk-Diffusion Method Levofloxacin Meropenem Microbicides Minocycline Normal Saline Pharmaceutical Preparations Piperacillin-Tazobactam Combination Product Polymyxins Sulbactam Susceptibility, Disease Tetracycline Tigecycline Tobramycin Trimethoprim-Sulfamethoxazole Combination
All VS-identified compounds were purchased from ChemScene (Monmouth Junction, NJ, USA) (Elbasvir and Velpatasvir); APExBIO (Houston, TX, USA) (Daclatasvir, Natamycin, and Saquinavir); 1PlusChem (San Diego, CA, USA) (Ceftaroline fosamil, Folinic acid, and Simeprevir); and AKScientific (Union City, CA, USA) (Ivermectin, Ledipasvir, Minocycline, and Telithromycin) and used as-is.
Full text: Click here
Publication 2023
ceftaroline fosamil daclatasvir elbasvir Ivermectin ledipasvir Leucovorin Minocycline Natamycin Saquinavir Simeprevir telithromycin velpatasvir

Top products related to «Minocycline»

Sourced in United States, Germany, United Kingdom, Macao
Minocycline is a tetracycline antibiotic used in laboratory settings. It has antimicrobial properties and is effective against a range of bacteria.
Sourced in United States, Sao Tome and Principe, Germany
Minocycline hydrochloride is a synthetic tetracycline antibiotic. It is a crystalline powder used in the formulation of pharmaceutical products.
Sourced in France, United States, Germany, Italy, Macao, United Kingdom, Sweden, Belgium, India, Japan, Brazil
The Vitek 2 system is an automated microbiology platform designed for the rapid identification and antimicrobial susceptibility testing of microorganisms. The system utilizes miniaturized biochemical testing to provide accurate results for a wide range of bacterial and yeast species.
Sourced in France, Sweden, United States, United Kingdom, Germany, Denmark, Italy, Australia, Spain, Switzerland, Japan
Etest is a quantitative antimicrobial susceptibility testing (AST) method developed by bioMérieux. It provides minimum inhibitory concentration (MIC) values for specific antimicrobial agents. Etest utilizes a predefined antimicrobial gradient on a plastic strip to determine the MIC of a tested microorganism.
Sourced in United States, Germany, United Kingdom, Italy, Spain, France, Sao Tome and Principe, Canada, Switzerland, China, India, Japan, Australia, Austria, Brazil, Denmark, Macao, Israel, Ireland, Argentina, Poland, Portugal, Czechia, Belgium
Gentamicin is a laboratory product manufactured by Merck Group. It is an antibiotic used for the detection and identification of Gram-negative bacteria in microbiological analysis and research.
Sourced in United States, Germany, United Kingdom, France, Canada, Macao, China, Switzerland, Japan, Italy, Sao Tome and Principe, Israel, Australia, Austria, Spain
Doxycycline is a broad-spectrum antibiotic belonging to the tetracycline class. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Doxycycline is commonly used in the treatment of various bacterial infections.
Sourced in United States, Germany, United Kingdom, France, Australia, Italy, Spain, Poland, Switzerland, India, Canada, Sao Tome and Principe, China, Ireland, Czechia, Japan, Macao, Israel, Belgium, Portugal
Ciprofloxacin is a broad-spectrum antibiotic that belongs to the fluoroquinolone class of antimicrobial agents. It is used in the treatment of various bacterial infections. Ciprofloxacin functions by inhibiting the activity of bacterial DNA gyrase and topoisomerase IV, which are essential enzymes for bacterial DNA replication and transcription.
Sourced in France, United States, Germany, Poland, Macao
The VITEK 2 Compact system is a compact automated microbiology instrument used for the identification and antimicrobial susceptibility testing of microorganisms. It is designed to perform rapid and accurate analysis of clinical samples in a laboratory setting.
Sourced in United States, Germany
M9511 is a versatile laboratory equipment product manufactured by Merck Group. It is designed for general laboratory use, providing a reliable and consistent performance for various applications. The core function of M9511 is to facilitate standard laboratory procedures and processes. Detailed specifications and intended use are not included in this factual description.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.

More about "Minocycline"

Minocycline, a tetracycline antibiotic, is widely used to treat a variety of bacterial infections.
It is effective against both gram-positive and gram-negative bacteria, and has proven useful in treating conditions like acne, rosacea, and other skin issues.
Minocycline works by interfering with bacterial protein synthesis, preventing the bacteria from replicating.
This versatile medication is available in both oral and topical formulations, and is generally well-tolerated, though it can occasionally cause side effects like discoloration of the skin and teeth.
Researchers continue to explore new applications and delivery methods for minocycline to optimize its effectiveness and safety.
Related terms and concepts include minocycline hydrochloride, a salt form of minocycline, the Vitek 2 system and Etest, which are laboratory methods used to test the susceptibility of bacteria to antibiotics like minocycline.
Other antibiotics that may be used alongside or compared to minocycline include gentamicin, doxycycline, and ciprofloxacin.
The VITEK 2 Compact system is a automated microbiology platform that can be used to identify and test the susceptibility of bacteria.
Minocycline (M9511) is a commonly studied strain, and fetal bovine serum (FBS) is a common cell culture supplement that may be used in minocycline research.
By leveraging the insights provided by these related terms and concepts, researchers can optimize their work with minocycline and enhance the reproducibility and accuracy of their studies.